Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carrier Proteins | 8 | 2025 | 1024 | 2.060 |
Why?
|
| Nuclear Proteins | 8 | 2025 | 1226 | 1.920 |
Why?
|
| DNA-Binding Proteins | 8 | 2025 | 1958 | 1.770 |
Why?
|
| DNA Replication | 5 | 2025 | 359 | 1.610 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2025 | 739 | 1.380 |
Why?
|
| Nucleotidyltransferases | 1 | 2025 | 46 | 0.930 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2020 | 482 | 0.880 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2020 | 53 | 0.760 |
Why?
|
| Membrane Proteins | 2 | 2025 | 1613 | 0.750 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2021 | 29 | 0.680 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2021 | 100 | 0.660 |
Why?
|
| Cell Cycle Proteins | 3 | 2021 | 703 | 0.620 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2020 | 60 | 0.560 |
Why?
|
| Mutation | 2 | 2025 | 6177 | 0.390 |
Why?
|
| Cell Line, Tumor | 5 | 2025 | 3673 | 0.380 |
Why?
|
| Mutation, Missense | 1 | 2017 | 929 | 0.370 |
Why?
|
| CCAAT-Binding Factor | 1 | 2011 | 6 | 0.360 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 356 | 0.350 |
Why?
|
| Phosphorylation | 4 | 2021 | 1571 | 0.350 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 489 | 0.290 |
Why?
|
| E2F1 Transcription Factor | 3 | 2020 | 49 | 0.280 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2357 | 0.220 |
Why?
|
| Chromatin | 2 | 2021 | 491 | 0.210 |
Why?
|
| Amino Acid Substitution | 2 | 2017 | 410 | 0.210 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2023 | 41 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 636 | 0.200 |
Why?
|
| Cell Line | 2 | 2020 | 2605 | 0.170 |
Why?
|
| G2 Phase | 1 | 2020 | 38 | 0.160 |
Why?
|
| S Phase | 1 | 2020 | 73 | 0.160 |
Why?
|
| Cyclins | 1 | 2020 | 94 | 0.160 |
Why?
|
| Protein Kinases | 1 | 2021 | 322 | 0.150 |
Why?
|
| Cell Division | 1 | 2020 | 731 | 0.140 |
Why?
|
| Cell Cycle | 1 | 2020 | 598 | 0.130 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 1397 | 0.130 |
Why?
|
| DNA Damage | 1 | 2021 | 527 | 0.130 |
Why?
|
| Gene Expression | 1 | 2021 | 1502 | 0.120 |
Why?
|
| DNA Helicases | 1 | 2017 | 230 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 1989 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2020 | 807 | 0.110 |
Why?
|
| Mice | 4 | 2025 | 18488 | 0.110 |
Why?
|
| Humans | 10 | 2025 | 131679 | 0.110 |
Why?
|
| Neoplasm Transplantation | 2 | 2014 | 361 | 0.110 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 261 | 0.110 |
Why?
|
| Protein Binding | 2 | 2020 | 1712 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2013 | 810 | 0.100 |
Why?
|
| Mice, Nude | 2 | 2013 | 714 | 0.100 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2013 | 46 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 135 | 0.100 |
Why?
|
| LIM Domain Proteins | 1 | 2013 | 67 | 0.100 |
Why?
|
| Animals | 5 | 2025 | 34375 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 57 | 0.100 |
Why?
|
| Serine | 1 | 2013 | 163 | 0.100 |
Why?
|
| Hydroxyurea | 1 | 2013 | 88 | 0.100 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 127 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2013 | 152 | 0.100 |
Why?
|
| Tumor Protein p73 | 1 | 2011 | 26 | 0.090 |
Why?
|
| Cyclin A | 1 | 2011 | 17 | 0.090 |
Why?
|
| CDC2 Protein Kinase | 1 | 2011 | 36 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 67 | 0.090 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2011 | 50 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2013 | 262 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 173 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 414 | 0.080 |
Why?
|
| RNA Interference | 1 | 2011 | 496 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 611 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 665 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2021 | 4683 | 0.070 |
Why?
|
| Neoplasms | 2 | 2014 | 2969 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 1218 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2463 | 0.050 |
Why?
|
| Female | 4 | 2025 | 71185 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2013 | 2437 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2023 | 147 | 0.050 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 20 | 0.040 |
Why?
|
| Sumoylation | 1 | 2020 | 41 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 195 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2020 | 113 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 2648 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2014 | 31 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 195 | 0.030 |
Why?
|
| Zyxin | 1 | 2013 | 4 | 0.020 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2013 | 19 | 0.020 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2013 | 32 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 62 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 989 | 0.020 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2013 | 81 | 0.020 |
Why?
|
| Cytosol | 1 | 2013 | 140 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 242 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2013 | 567 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 832 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 881 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2013 | 346 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 455 | 0.020 |
Why?
|
| Glioma | 1 | 2013 | 498 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1861 | 0.020 |
Why?
|